New cancer drug SG2918 enters first human safety trial
NCT ID NCT06167486
First seen Mar 25, 2026 · Last updated May 15, 2026 · Updated 7 times
Summary
This early-stage study tests a new drug called SG2918 in 17 people with advanced cancers that have not responded to standard treatments. The main goal is to check if the drug is safe and tolerable, and to see early signs of whether it can help control the disease. Participants receive the drug and are closely monitored for side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, 400000, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410031, China
-
Shanghai first maternity and infant hospital
Shanghai, Shanghai Municipality, 200126, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, 30013, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310005, China
Conditions
Explore the condition pages connected to this study.